Literature DB >> 1316045

Fetal death following labetalol administration in pre-eclampsia.

K S Olsen1, R Beier-Holgersen.   

Abstract

Labetalol (Trandate) 50 mg i.v. was administered to a pre-eclamptic primigravida with an asphytic fetus prior to cesarean section, in order to reduce the risk of excessive increase in blood pressure during induction of anesthesia. Blood pressure fell rapidly from 170/110 to 115/85 mmHg. A dead infant was born. Oral labetalol is arguably a suitable remedy for pre-eclampsia, but if i.v. administration is necessary, an initial dose of 5-10 mg is recommended.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316045     DOI: 10.3109/00016349209007974

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Adverse neonatal effects of maternal labetalol treatment.

Authors:  B N Crooks; S A Deshpande; C Hall; M P Platt; D W Milligan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

2.  Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.

Authors:  Laura A Magee; Chris Cham; Elizabeth J Waterman; Arne Ohlsson; Peter von Dadelszen
Journal:  BMJ       Date:  2003-10-25

Review 3.  Pre-eclampsia: pathophysiology, diagnosis, and management.

Authors:  Jennifer Uzan; Marie Carbonnel; Olivier Piconne; Roland Asmar; Jean-Marc Ayoubi
Journal:  Vasc Health Risk Manag       Date:  2011-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.